Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged Topical Steroids After Low-risk Penetrating Keratoplasty
NCT00450996Phase 3Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Jan 1999
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial of prednisolone in graft rejection (2 arms), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Primary endpoint: Graft survival. Started Jan 1999; status: completed.
02
Drugs
prednisolone
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT00450996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450996.